K. Jones

发表

Relative difficulty of examinations in different subjects

R. Coe, S. Higgins, J. Searle, 2008 .

A pathogenesis‐related protein GmPR08‐Bet VI promotes a molecular interaction between the GmSHMT08 and GmSNAP18 in resistance to Heterodera glycines

C. Bergounioux, M. Benhamed, K. Lambert, 2020, Plant biotechnology journal.

Schizophrenia, tardive dyskinesia, and brain GABA

K. Jones, T. Perry, S. Hansen, 1989, Biological Psychiatry.

N-benzylpiperazine has characteristics of a drug of abuse

P. Fitzmaurice, K. Jones, D. Gittings, 2007, Behavioural pharmacology.

Tetrahydroisoquinoline lacks dopaminergic nigrostriatal neurotoxicity in mice

K. Jones, T. Perry, S. Hansen, 1988, Neuroscience Letters.

4-Phenylpyridine and three other analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine lack dopaminergic nigrostriatal neurotoxicity in mice and marmosets

K. Jones, R. Wall, T. Perry, 1987, Neuroscience Letters.

Paraquat and two endogenous analogues of the neurotoxic substance N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine do not damage dopaminergic nigrostriatal neurons in the mouse

V. Yong, K. Jones, R. Wall, 1986, Neuroscience Letters.

Manipulation of glutathione contents fails to alter dopaminergic nigrostriatal neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse

V. Yong, K. Jones, T. Perry, 1986, Neuroscience Letters.

Tolerance to the Behavioural and Neurochemical Effects of MDMA Following Repeated Exposure

K. Jones, 2009 .

Application of Blissymbolics to the non-vocal communicatively handicapped

K. Jones, 1977 .

Exposure to cigarette smoke does not decrease the neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice

Shirley Hansen, K. Jones, Thomas L. Perry, 1987, Neuroscience Letters.

2-Phenylpyridine and 3-phenylpyridine, constituents of tea, are unlikely to cause idiopathic Parkinson's disease

Shirley Hansen, Richard A. Wall, K. Jones, 1988, Journal of the Neurological Sciences.

But I Was Counting On You

K. Jones, 2017 .